Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:05 pm Sale |
2024-12-31 | 13G | SLM Corporation SLM |
Boston Partners | 11,299,020 5.320% |
-9,107,914 (-44.63%) |
Filing History |
| 2025-02-13 09:59 am Sale |
2024-12-31 | 13G | SLM Corporation SLM |
MASSACHUSETTS FINANCIAL SERVICES CO | 10,123,065 4.800% |
-1,924,895 (-15.98%) |
Filing History |
| 2025-01-31 09:54 am Sale |
2024-12-31 | 13G | SLM Corporation SLM |
The Vanguard Group | 28,795,311 13.560% |
-4,341,473 (-13.10%) |
Filing History |
| 2025-01-28 6:17 pm Sale |
2025-01-24 | 13D | SLM Corporation SLM |
Impactive Capital LP | 11,532,399 5.400% |
-3,874,901 (-25.15%) |
Filing History |
| 2024-11-27 4:45 pm Sale |
2024-11-25 | 13D | SLM Corporation SLM |
Impactive Capital LP | 15,407,300 7.300% |
-4,592,700 (-22.96%) |
Filing History |
| 2024-10-04 3:41 pm Unchanged |
2024-09-30 | 13G | SLM Corporation SLM |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-07-25 10:04 am Purchase |
2024-06-30 | 13G | SLM Corporation SLM |
First Trust Portfolios L.P. | 14,643,555 6.660% |
14,643,555 (New Position) |
Filing History |
| 2024-02-13 5:14 pm Purchase |
2023-12-29 | 13G | SLM Corporation SLM |
The Vanguard Group | 33,136,784 14.640% |
1,519,204 (+4.80%) |
Filing History |
| 2024-02-13 1:49 pm Sale |
2023-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC | 12,265,852 5.421% |
-4,296,594 (-25.94%) |
Filing History |
| 2024-02-09 11:49 am Sale |
2024-02-09 | 13G | SLM Corporation SLM |
MASSACHUSETTS FINANCIAL SERVICES CO | 12,047,960 5.300% |
-5,408,906 (-30.98%) |
Filing History |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | SLM Corporation SLM |
BLACKROCK INC BLK |
19,920,050 8.800% |
-2,132,196 (-9.67%) |
Filing History |
| 2023-06-05 4:31 pm Sale |
2023-06-01 | 13D | SLM Corporation SLM |
Impactive Capital LP | 20,000,000 8.300% |
-2,593,389 (-11.48%) |
Filing History |
| 2023-02-13 10:49 am Purchase |
2022-12-30 | 13G | Prelude Therapeutics Incorporated PRLD |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC | 16,562,446 6.620% |
16,562,446 (New Position) |
Filing History |
| 2023-02-09 11:32 am Sale |
2022-12-30 | 13G | SLM Corporation SLM |
The Vanguard Group | 31,617,580 12.640% |
-2,238,214 (-6.61%) |
Filing History |
| 2023-02-08 4:07 pm Sale |
2023-02-08 | 13G | SLM Corporation SLM |
MASSACHUSETTS FINANCIAL SERVICES CO | 17,456,866 7.000% |
-130,914 (-0.74%) |
Filing History |
| 2023-01-30 11:32 am Sale |
2023-01-11 | 13G | SLM Corporation SLMBP |
Barclays PLC | 355,801 14.170% |
-131,598 (-27.00%) |
Filing History |
| 2023-01-25 10:36 am Sale |
2022-12-31 | 13G | SLM Corporation SLM |
BLACKROCK INC BLK |
22,052,246 8.800% |
-2,418,628 (-9.88%) |
Filing History |
| 2022-08-01 4:20 pm Purchase |
2022-07-28 | 13D | SLM Corporation SLM |
Impactive Capital LP | 22,593,389 9.000% |
4,162,550 (+22.58%) |
Filing History |
| 2022-05-03 4:20 pm Purchase |
2022-04-29 | 13D | SLM Corporation SLM |
Impactive Capital LP | 18,430,839 6.800% |
2,945,680 (+19.02%) |
Filing History |
| 2022-03-10 4:20 pm Purchase |
2022-02-28 | 13D | SLM Corporation SLM |
Impactive Capital LP | 15,485,159 5.500% |
15,485,159 (New Position) |
Filing History |